Covid-19 Update

Debate between Matt Hancock and Greg Clark

Monday 14th June 2021 Commons Chamber

[Matt Hancock]

I am happy to raise that for the hon. Gentleman. I almost thought he was going to say, at the end of that, that he was glad that Britain now controls its own borders.

[Greg Clark (Tunbridge Wells) (Con)]

Young people have made big sacrifices during the pandemic and seen two years of their lives disrupted. Many students and school leavers will be leaving school and university between now and 19 July, so will the Secretary of State confirm that what he said in his statement about removing the 30-person limit on commemorative events will include graduation ceremonies and school-leaving parties in commercial venues? After all, school students in particular have been educated in bubbles with each other for months now, and it would add insult to injury if they were to be denied an opportunity to say farewell to each other.

[Matt Hancock]

I will ensure that the precise Cabinet Office guidance reaches my right hon. Friend’s mobile phone as soon as possible. I am now an hour and five minutes into this, and I am afraid I am going to have to get back to him on that one.

Covid-19 Update

Debate between Matt Hancock and Greg Clark

Monday 17th May 2021 Commons Chamber

[Matt Hancock]

I answered those questions in response to the right hon. Member for Leicester South (Jonathan Ashworth). The truth is that when we put Pakistan and Bangladesh on the red list, positivity among those arriving from those countries was three times higher than it was among those arriving from India. That is why we took those decisions and, of course, they were taken before the Indian variant became a variant under investigation, let alone a variant of concern. It is striking that the Scottish Government took the decision to put India on the red list at the same time as we in the UK Government did. It is all very well to ask questions with hindsight, but we have to base decisions and policy on the evidence at the time.

When it comes to how we are tackling the virus in the UK, the hon. Lady is quite right that it is good news—albeit early news—that the vaccines do appear to be effective against the B1617.2 variant. I am obviously pleased about the evidence we have seen but we are vigilant about that. I am glad that the approach we are now taking in Bolton and Blackburn worked against the South African variant in south London. We always keep these things under review, but I think that as a first resort, surge testing, going door to door, ensuring that we find and seek out the virus wherever we can spot it, and putting in the extra resources with the armed services who are supporting us, are the right approaches while we keep this under review. The numbers thus far nationally are still relatively low and, thankfully, we have a very good surveillance operation across the UK so that we can spot these things early and take the action that we need to.

[Greg Clark (Tunbridge Wells) (Con)]

Does my right hon. Friend agree with Sir Patrick Vallance, who told my Committee that new variants will arise all the time and that border restrictions will only slow, not prevent, those variants that originate overseas? What level of vaccination protection do we need to get to in this country before my right hon. Friend is in a position to rescind the rather strange advice that he has just given to my right hon. Friend the Member for South West Surrey (Jeremy Hunt) and allow people who have been tested three times and quarantined for 10 days to travel to places such as France and Spain?

[Matt Hancock]

Typically my right hon. Friend asks the most pertinent question, to which we do not know the answer. The level of vaccination that we need in order to withstand the incursion of new variants, even those that the vaccine will work against, depends on their level of transmissibility, and we do not know the increased level of transmissibility over and above that of B117, the previous main variant here in the UK, which was first discovered in Kent. This is an absolutely critical question, but unfortunately we do not know the answer to it yet.

Coronavirus

Debate between Matt Hancock and Greg Clark

Thursday 25th March 2021 Commons Chamber

[Matt Hancock]

I just want to answer my hon. Friend’s second point before taking further interventions. His point about long covid is important. In fact, the National Institute for Health Research, which has done a brilliant job during the pandemic, has today put out a £20 million call for further research and diagnostics, including patient and public involvement, so that long covid can be properly understood, and people who catch covid and have symptoms over a long time—which I know can be deeply debilitating for some people—can get the support they need on the NHS.

[Greg Clark (Tunbridge Wells) (Con)]

My right hon. Friend mentions the fact that we live with flu every winter and act against it. Has he made an assessment of what level of hospital admissions would be consistent with protecting the NHS?

[Matt Hancock]

It is very difficult to know in advance. At the peak of this pandemic, we had 38,000 patients in hospital across the UK at any one time with covid, but of course that meant that other non-urgent treatments had to be delayed. There is a question of the trade-off and how much treatment is delayed. In a bad flu season, elective operations and non-urgent treatments are delayed. That is one way in which the NHS manages through a difficult flu season in winter. Measures like that will be necessary if we have an increase in covid cases.

If we have learned anything in the last year, we have learned that we have to live with risk as a society. That is a reality, so the goal and the strategy are to invest in the NHS so that it has more capacity, make sure that it can expand capacity and make sure that we have the vaccine effort and the continued efforts that people will no doubt take personal responsibility for, such as mask-wearing—and people will be highly likely do that to protect themselves and others, after the experience we have just had. I want to get to a point of personal responsibility plus the vaccine plus the test and trace programme, so that people can be regularly tested and we can use that to break the chains of transmission. I want to manage covid in that way, while restoring our freedoms. That is the best way, once we have made our way carefully down this road.

Covid-19 Update

Debate between Matt Hancock and Greg Clark

Thursday 17th December 2020 Commons Chamber

[Matt Hancock]

We are working on exactly that proposal, because the need to use testing and use the easily available and rapid-return lateral flow devices is incredibly important. They have an important role to play, used in the right settings, in the same way that the PCR tests have an important role to play, but it takes longer to get the results back with those tests. I look forward to working with the hon. Lady, with Luton council, and with all those across Bedfordshire to try to get this sorted. Clearly, case rates in Bedfordshire are shooting up in a very worrying way, and I thank her for her efforts and public health messaging to say to everybody right across Bedfordshire, including in Luton, “Let’s work together to get this sorted.”

[Greg Clark (Tunbridge Wells) (Con)]

I asked my right hon. Friend to consider restrictions on a more local level than county-wide, and I am grateful that he has done so across the country today. Infections in Tunbridge Wells, while much lower than the average for the county of Kent as a whole, are nevertheless rising, and there is pressure on the local NHS, so I understand why there is no change from tier 3 today. However, will the Secretary of State commit to apply the five tests fortnightly, and to reduce our level of restrictions as soon as they are met? Will he also have a word with the Chancellor to see what extra support can be given to businesses in the hospitality sector, which have just lost the most important part of the trading year in what has been a miserable year for them?

[Matt Hancock]

Yes, of course I will talk to the Chancellor about the point that my right hon. Friend raises. Of course, we do already have a significant amount of support for hospitality businesses, but I understand how difficult this is.

On the point about looking at local areas, we will absolutely do so, as we have demonstrated in the decisions taken today. For instance, just over the border in East Sussex, we have unfortunately had to put Hastings and Rother into tier 3. Tunbridge Wells today has a case rate of 288 per 100,000, and I would say to everybody right across Kent that we really need to act with serious responsibility. No matter which part of Kent a person is in, we have a very serious problem in Kent, and the only way in which we can get it under control is for people in Kent to essentially behave as if they have the virus and are trying not to pass it on to somebody else. Be really cautious in Kent: it is the area of the country that has the biggest problem in terms case rates, and therefore there are huge pressures on the NHS in Kent. I thank everyone who works in the NHS in Kent for what they are doing.

We are putting in as much support as we can, and I look forward to working with my right hon. Friend, all colleagues from across Kent and of course the county council and district councils to try to get this under control. Other parts of the country have done it and brought the case rate down, and we have been able to take some into tier 2. I am sure that we can get there in Kent, but we have to work hard to make that happen.

Coronavirus Vaccine

Debate between Matt Hancock and Greg Clark

Wednesday 2nd December 2020 Commons Chamber

[Matt Hancock]

Yes, I can give that assurance. I join the hon. Gentleman in thanking the volunteers, whom I should have thanked in response to an earlier question, and also thank in advance everybody in the NHS who is going to be involved in this roll-out. It is going to be a mammoth effort—people are going to be working really hard this winter, when people already work hard during winter in the NHS—and I am sure that the whole House is very grateful to them.

[Greg Clark (Tunbridge Wells) (Con)]

I join the Secretary of State in thanking the scientists who were involved in this major breakthrough for their brilliance and hard work, and I join my right hon. Friend the Member for South West Surrey (Jeremy Hunt) in paying a personal tribute to the Secretary of State, who has been tenacious, positive and energetic right throughout this. We are the first in the world and a lot of that is down to him.

We need to keep the virus suppressed during the months ahead. One of the problems with test and trace is that quite often people do not disclose all their contacts because they do not want them to have to isolate for two weeks. Sir John Bell, whom I know the Secretary of State admires as much as I do, suggests that if we subject people who are isolated to two tests and they are both negative, they should be released. He thinks that will safely encourage people to share their contacts and suppress the spread of the virus. The Secretary of State has moved heaven and earth on vaccination; will he do this for test and release?

[Matt Hancock]

It is a great day for science and a great day to be Chair of the Science and Technology Committee, I would have thought. I am grateful to my right hon. Friend for what he said, which was very generous.

On the point about repeat testing instead of isolation for contacts, that is something we are trialling right now, and I hope we can make significant progress on it in the weeks ahead.

Covid-19: Winter Plan

Debate between Matt Hancock and Greg Clark

Monday 23rd November 2020 Commons Chamber

[Matt Hancock]

I pay tribute to all those who have been working on the coronavirus response and, more broadly, all those who have been working together across the public and private sectors to make it happen. There are clear, significant economic consequences to the actions that we have had to take, and we as a country will have to get through those in the same way as we have pulled together to get through this coronavirus crisis so far. We are not there yet, but we are making significant progress.

[Greg Clark (Tunbridge Wells) (Con)]

The scientists, their teams and all the volunteers deserve our thanks for getting the breakthrough with the vaccine, as do the Secretary of State and the Government for funding that research and for acting in anticipation by buying 100 million doses of the vaccine. In that spirit, and given that we have made this commitment, will he over the next couple of days ask the Chancellor to advance some of the money that the Prime Minister referred to—the record-breaking increase in science funding—and put it in the hands of other clinical trials that are funded by charitable funds but whose fundraising income has dropped, so that there is no interruption to life-saving research for cancer and other sources?

[Matt Hancock]

My right hon. Friend tempts me to give an answer ahead of its time. Like him, I look forward to hearing what the Chancellor of the Exchequer will have to say on Wednesday.

Covid-19 Update

Debate between Matt Hancock and Greg Clark

Programme motion
Monday 19th October 2020 Commons Chamber

[Matt Hancock]

The hon. Lady is absolutely right to raise that issue. In my statement, I said that we have managed to reduce the backlog among the longest waiters, those who wait more than 104 days, by more than 63% and among those waiting more than 62 days by 44%. There is further work to do—of course there is—but the NHS has made significant strides on the backlog of people waiting for cancer treatment, and I pay tribute to all the work that it has done.

[Greg Clark (Tunbridge Wells) (Con)]

The concern that many of us have is that restrictions can be imposed in a day, but take months to lift. In London, the restrictions were imposed not because of a higher level of infections, admissions to hospital or deaths, but because of a rapidly increasing rate of infection. If it turns out, when the Secretary of State conducts his fortnightly review next week, that the rate of increase of infection is no greater in London than in places in a lower tier, will he rescind those restrictions and return it to a lower tier?

[Matt Hancock]

My right hon. Friend makes an important point and, in a way, highlights that it is not just the case rate that matters; it is also the rate of change of the case rate, the over-60s case rate and the impact on hospitals. In the case of London, cases are over 100 per 100,000, which is a worrying level, but I really hope that the measures, and the people of London and all those who work here, can bring the case rate down so we can get out of it as fast as possible. Team London is, in fact, working on a proposed strategy for coming out of level 2, but the first thing that everybody in London has to do is follow the rules to get the rate of increase down, because it is only then that we can even start to consider the next steps.

Covid-19 Update

Debate between Matt Hancock and Greg Clark

Thursday 15th October 2020 Commons Chamber

[Matt Hancock]

We are putting in more support and if any area goes into the third level, into tier 3, it gets further support. We are putting more into local test and trace, although on its own that will not work as effectively as the partnership, which is, as I said from the figures, improving and expanding all the time. I welcome the fact that the hon. Lady recognises the sharp rise in cases in Greater Manchester and the need to act. I very much hope that we can act on a cross party basis, but act we must.

[Greg Clark (Tunbridge Wells) (Con)]

A lot of weight is being shouldered by the Joint Biosecurity Centre, which is engaged in decisions that are having big consequences for millions of people across the country. It is concerning that there was nothing in the Secretary of State’s statement about the criteria for exiting these measures.

When the Joint Biosecurity Centre was created on 20 May, SAGE was told that it would

“pursue a reputation as an organisation that the public can trust. This will require them to be an exemplar in terms of honesty, openness, competence and independence.”

Yet nearly five months on, it has not disclosed the minutes of any of its meetings, the papers that it has drawn on or even who sits on its boards, despite a commitment on its own website to do so. If it is to be the exemplar that it has been billed to be and if the public are to have trust in it given the importance of these decisions, will the Secretary of State order that openness without delay?

[Matt Hancock]

In fact, very shortly the Joint Biosecurity Centre will be making further of its analysis public. It works within the Department and its officials are civil servants, so it is different from SAGE, which is made up of independently employed scientists. Nevertheless, my right hon. Friend makes an important point, on which we are acting.

Covid-19 Update

Debate between Matt Hancock and Greg Clark

Monday 5th October 2020 Commons Chamber

[Matt Hancock]

On the core of the hon. Lady’s point, the assessment of the epidemic on the basis of the updated data is core to our approach to tackling the epidemic. The chief medical officer has analysed the new data, which we have now published—on coronavirus.data.gov.uk we can see the data, and that is on the corrected basis. Based on Joint Biosecurity Centre analysis, the CMO’s advice is that the assessment of the disease and its impact have not substantially changed. That is because the just under 16,000 cases were essentially evenly spread, so it has not changed the shape of the epidemic. It has changed the level, in terms of where we are finding the epidemic and in what sorts of groups.

The hon. Lady asks how many contacts have been contacted, as opposed to how many of the primary index cases. As I said, that is happening concurrently, so as soon as the index case has been contacted by Test and Trace and interviewed, the contacts are immediately contacted. As I said, we have got through 51% of the backlog over the weekend, and we have brought in more resources to complete that task.

[Greg Clark (Tunbridge Wells) (Con)]

My right hon. Friend and everyone in the House hopes that there will be a safe and effective vaccine available during the months ahead, but the head of the vaccines taskforce has said that she expects it to be available to only half of the population, concentrating on the over-50s and the most vulnerable. Is that the Secretary of State’s understanding? What are the implications for the other half of the population?

[Matt Hancock]

This is a very important question. The vaccines taskforce has done incredibly important work in supporting the scientific development and manufacture of vaccines and in procuring vaccines—six different types of vaccine—from around the world. The work of deploying a vaccine is for my Department, working with the NHS and the armed forces, who are helping enormously with the logistical challenge, and we will take clinical advice on the deployment of the vaccine from the Joint Committee on Vaccination and Immunisation. My right hon. Friend the Chair of the Science and Technology Committee will know that 10 days ago the JCVI published a draft prioritisation, and it will update that as more data becomes clear from the vaccine. That is the Government’s approach: to take clinical advice from the JCVI.

Covid-19 Update and Hospitality Curfew

Debate between Matt Hancock and Greg Clark

Thursday 1st October 2020 Commons Chamber

[Matt Hancock]

What I say is that we do what is necessary because it saves lives and we understand the impact that it has. The message that I would send to everybody in Bradford is that, the more that they follow the rules that are in place, the faster we will be able to get through this.

[Greg Clark (Tunbridge Wells) (Con)]

It does seem strange to think that concentrating trade in a smaller number of hours and making everyone leave a pub or restaurant at the same time, rather than spacing them out over the course of the evening, should suppress rather than spread the virus. Will the Secretary summarise the scientific advice that he has had on this point?

[Matt Hancock]

The scientific advice is that the people who are closer together are more likely to spread the virus and that, later at night, social distancing becomes harder. We have all seen the pictures of people leaving pubs at 10 o’clock, but otherwise they would be inside the establishments, and we all know that outside is safer, or they would be leaving later. Of course we keep this under review and of course we are constantly looking at how we can improve these policies, but I think that we have to look at both sides of the evidence to try to get this right.

Covid-19 Update

Debate between Matt Hancock and Greg Clark

Monday 21st September 2020 Commons Chamber

[Matt Hancock]

Care home testing is incredibly important. We have brought down some of the response times, and I am glad to report to the House that, since last week, when we debated the very sharp rise in demand, including among asymptomatic people, that demand has come down somewhat, and the pressures are a little lower on the testing system as a whole. That does not mean that we do not want to increase capacity further—of course we do. It is very important that we have tests available for all vulnerable people, whether they live at home or in a care home.

[Greg Clark (Tunbridge Wells) (Con)]

The scientific evidence is that covid is detectable by test within seven days of someone being infected, so why should people who have been made to self-isolate not be tested seven days after a possible infection and released if they test negative?

[Matt Hancock]

The incubation period before which the virus can present itself is still estimated to require 14 days of self-isolation. If we could bring that figure down, I would be the first to be pleased to do so. As with our decision to take to 10 days the period for which somebody who has tested positive must self-isolate, this is a critical point, and we must rely on the scientific evidence. If my right hon. Friend has further scientific evidence, I would be happy to look at it.

Covid-19 Update

Debate between Matt Hancock and Greg Clark

Thursday 10th September 2020 Commons Chamber

[Matt Hancock]

I was in contact with the Mayor of Greater Manchester this morning on the question of what we do in Greater Manchester. The national measures that were announced yesterday will come into force in Greater Manchester, and it is important that people follow them. We took further action in Bolton. The case rate in Bolton was coming down well, but thankfully before we implemented the rule change to remove some of the restrictions, we were able to act and stop that relaxation from happening, and we then had to tighten the rules up. I am working closely with councils in Greater Manchester, and talking to the Mayor, and I will also take on board the hon. Gentleman’s views in ensuring that we get these measures right. The message to everyone in Greater Manchester is the same as it is across the country: follow the rules and follow the social distancing, because only by doing that can we get this under control.

[Greg Clark (Tunbridge Wells) (Con)]

The  Secretary of State must accept that there is a problem here. Constituents of mine in Kent displaying symptoms of covid were this week advised to go for tests in Bude in Cornwall and Galashiels in Scotland—and this is in a mild September, before the autumn and winter when people have coughs and colds that may look like symptoms of covid. It is no good blaming people who are asymptomatic. I would be interested if the Secretary of State could say what percentage of people turning up for testing do not have symptoms. This situation needs his personal grip. He referred to the need for him to increase testing capacity from 1,000 a day to 100,000 a day. This is an urgent matter that he needs to grip before the autumn and winter bites. Will he commit to ensuring that by the end of the month anyone who has symptoms of covid can get a test at a reasonable place that is convenient to their home?

[Matt Hancock]

It is of course my goal for that to happen immediately. The challenge is to increase capacity—a subject that my right hon. Friend and I have discussed at length, and of which I know he is a strong supporter—and to make sure that that capacity is used by the right people. That is why I am clear about the eligibility for testing. It is really important that people hear the message that if they have symptoms, of course they should get a test; we urge them to get a test because we need to find out if it is covid for their sake and for everybody else’s. But at the same time, it is important that people who are not eligible do not come forward for tests because they are taking a test away from somebody who has symptoms. Yes, I want to solve this with ever more capacity, but I also want to ensure that the tests are used by the right people.

Coronavirus Response

Debate between Matt Hancock and Greg Clark

Monday 20th July 2020 Commons Chamber

[Matt Hancock]

Teasing out the answer to that question is a difficult statistical task, but the broad point the hon. Gentleman makes is the right one. We are seeking to tackle this disease, coronavirus, and we have to measure that; at the same time, of course, we need to continue to tackle all the other diseases and to make sure that the consequences of those diseases are measured properly. It is a significant challenge that faces many countries around the world, and that is why scientists are somewhat sceptical about over-analysis and international comparisons of deaths data, as proven by the need for the urgent review I put in place last week.

[Greg Clark (Tunbridge Wells) (Con)]

As my right hon. Friend knows, if we are to suppress the virus, we need an agile and vigorous response. Six weeks ago, I asked him to ensure that tests were available to elderly residents not only of care homes but in sheltered accommodation and retirement villages. Three weeks ago, he told me that they

“will be rolled out over the coming three to four weeks”.—[Official Report, 29 June 2020; Vol. 678, c. 117.]

Can he confirm whether that is now complete, or will be by the end of the week?

[Matt Hancock]

I will bring the answer to that question to the Science and Technology Committee, which my right hon. Friend chairs, tomorrow. I commissioned an answer to precisely that question ahead of that appearance and was hoping that he would ask a different question today, but I have been found out.

Covid-19 Update

Debate between Matt Hancock and Greg Clark

Thursday 16th July 2020 Commons Chamber

[Matt Hancock]

I am very happy to ensure that the social care Minister meets the hon. Lady as soon as possible.

[Greg Clark (Tunbridge Wells) (Con)]

The Secretary of State is assiduous and energetic in making himself available to answer questions at all times, and I am grateful that he has agreed to come before my Committee next week so that we have longer than we would have had today given this statement. In March, we did not have the testing capacity in place to cope with the volume of testing that was needed, and it took until May to get it. Sir Patrick Vallance said to the Science and Technology Committee this afternoon that we do not currently have the testing capacity needed for the coming winter. Will the Secretary of State guarantee that it will be available long before then, and that we do not repeat one of the principal mistakes of the current pandemic?

[Matt Hancock]

I was heavily and personally involved in making sure there was that rapid increase in testing capacity back then, and I am determined to ensure that the testing that we need for this winter is available. We have plans in place to deliver it. Of course, that needs to be built; it is not there now, but it will be built. Even if there are no breakthroughs on testing technology that would make testing much easier to access, we have plans to ensure that the testing capacity that is necessary for winter will be available by winter.

Coronavirus Update

Debate between Matt Hancock and Greg Clark

Tuesday 14th July 2020 Commons Chamber

[Matt Hancock]

We are working on exactly that. This is part of a number of questions that rightly have been asked about the long-term impact of covid and making sure we have the NHS treatment available for it.

[Greg Clark (Tunbridge Wells) (Con)]

Asymptomatic workers in care homes are now tested every week. Asymptomatic workers in hospitals are not. Why not?

[Matt Hancock]

The programme that we have in hospitals is a risk-based one, according to the risk of the individual. It is much harder to put that risk base in place in care homes. Both of these proposals, while seemingly different, are based on the same clinical advice.

Covid-19 Update

Debate between Matt Hancock and Greg Clark

Monday 29th June 2020 Commons Chamber

[Matt Hancock]

I think the best way to explain that is that all the data we have on Leicester has been made available to Leicestershire County Council. I pay tribute to Ivan Browne, director of public health at Leicester City Council, who has done a superb job through this. All the data available to us is available to him. Indeed, I can commit to the House that we will publish all the data on test results, in order to ensure that the wider public, as well as directors of public health, are able to access that data.

The hon. Lady frequently tries to divide the testing system between those tests done in hospital labs and those done in the labs that we have built over the past few weeks. That is the wrong approach—it is only because we managed to build those labs that we have such large testing capacity across the UK. Those tests from the lighthouse labs are available in Scotland, Wales and Northern Ireland, as well as England. I pay tribute to the work of those labs, which have done so much to deliver what is now an extraordinary testing capability that we can bring to bear on specific problems, such as this one in Leicester.

[Greg Clark (Tunbridge Wells) (Con)]

As the Secretary of State said, speed is of the essence in responding to the pandemic. However, on 8 June, in the Chamber, I asked my right hon. Friend to intervene immediately to correct the situation that elderly people and people with physical and learning disabilities in supported and sheltered accommodation cannot get testing kits. Three weeks later, they still cannot. How can we have confidence in a speedy and targeted approach to testing and tracing if those of great vulnerability still cannot be tested three weeks after a clear commitment was given to grip the matter?

[Matt Hancock]

I am grateful to my right hon. Friend for his question. I am pleased to be able to say that we are now rolling out testing to the settings that he describes. This will be rolled out over the coming three to four weeks, to coincide with the time that it will take us to build that roll-out capacity. It is important that, first, that testing is where it needs to be, and secondly, that we do that on the basis of clinical need, which is why we supported testing in nursing homes and residential homes first.

Covid-19: R Rate and Lockdown Measures

Debate between Matt Hancock and Greg Clark

Monday 8th June 2020 Commons Chamber

[Matt Hancock]

The hon. Lady is right to ask that question. On the clinical advice, and indeed the scientific advice that we were just discussing, we introduced whole-home testing for residents and staff to care homes for older people, because older people are 70 times more likely to die from covid-19 than those who are younger, which is a significant age gradient. Now that we have got tests to all eligible care homes for the elderly, we are moving to delivering the same thing for people of working age.

[Greg Clark (Tunbridge Wells) (Con)]

The Secretary of State is quite right that it is important to protect our older citizens. It is true that older people and workers in care homes are able to get tests, but that is not the case for people who live or work in retirement villages and supported accommodation. Will he intervene to correct that anomaly immediately, so that we can protect all our older and vulnerable people?

[Matt Hancock]

Yes, of course, that is taken into account in the clinical decision on the order of priority for testing. My right hon Friend makes a very important point that I will ensure is taken away and looked at, to check this for people in those settings outside formal social care, which are often not Care Quality Commission registered but still have a much higher proportion of elderly people who are vulnerable to this disease in them. I will ensure that that is properly looked into and, if I may, I will write to the Chair of the Science and Technology Committee on that point.

Covid-19 Response

Debate between Matt Hancock and Greg Clark

Wednesday 22nd April 2020 Commons Chamber

[Matt Hancock]

The hon. Lady asks a number of questions. First, on the living wage, all health and social care staff in the UK are paid the living wage, because that is the law. I am very proud that we introduced the living wage, which has led to a significant rise in pay, especially for people in social care who were on the minimum wage previously. She asks about asymptomatic transmission. The scientific evidence shows that asymptomatic transmissions occurs, which is one of the very significant challenges that this virus presents. She also asked about test, track and trace. I absolutely agree that that is a critical part of keeping the spread of this virus low. The lower the number of new cases is, the more effective test, track and trace is. We are therefore building now the capacity for the very large-scale contract tracing necessary to go alongside the large-scale testing—the 100,000 tests at the end of this month that I mentioned in my statement—and the technology that can help us to do that.

[Greg Clark (Tunbridge Wells) (Con) [V]]

It is important that decisions should be informed by good advice, so has SAGE advised on whether the 100,000 tests a day target is the right one?

[Matt Hancock]

The target was set at 100,000 because that is what we estimated was needed—scientific advice was provided into that target—and it is what is practically achievable. As I said, we are ahead of our trajectory on capacity, but we need to make sure that demand increases. Increasing demand is about widening access to this testing. We did take scientific advice. I am not sure whether that came directly through the SAGE route or directly from Public Health England, but of course these decisions are based on the science.

Coronavirus Bill

Debate between Matt Hancock and Greg Clark

2nd reading & 2nd reading: House of Commons
Monday 23rd March 2020 Commons Chamber

[Matt Hancock]

Yes. I will turn to this point shortly, but let me just correct my right hon. Friend. The measures we are taking to be able to hold people in quarantine build on those in the Public Health (Control of Disease) Act 1984, which we have been using hitherto. In that element, the Bill is not unprecedented. The Bill makes these powers UK-wide and strengthens the basis on which they can be exercised, but the powers are not unprecedented. Nevertheless, the point he makes about the House’s ability to scrutinise these measures and to ensure that we are, as a House, content with their continuation is important.

[Greg Clark (Tunbridge Wells) (Con)]

Will my right hon. Friend give way?

[Matt Hancock]

Let me make a little more progress in answering my right hon. Friend the Member for Gainsborough (Sir Edward Leigh), and then of course I will give way.

The Bill is jointly agreed between the four UK Governments. Of course, there are measures that are significant departures from the way we normally do things, but they are strictly temporary. I think that they are proportionate to the threat we face, and they will be activated only on the basis of the best possible scientific evidence. Crucially, to my right hon. Friend’s point, the legislation is time-limited for two years and the measures can each be switched on and off individually as necessary by the relevant authority, whether that is the UK Government or the devolved Government, depending on who exercises the powers. As an additional safeguard, we today tabled an amendment to give the House the opportunity to confirm that the powers are still required every six months.

[Greg Clark]

I am grateful to my right hon. Friend for giving way. Everyone admires the steps he is taking. He knows that I have been questioning and corresponding with him on testing for some time. Given that, as he pointed out, the test was developed in this country, can he explain why it seems to be so much less available in this country than in other countries around the world?

Covid-19

Debate between Matt Hancock and Greg Clark

Monday 16th March 2020 Commons Chamber

[Matt Hancock]

I entirely understand that point. I want to get testing to everyone who needs it as soon as possible.

[Greg Clark (Tunbridge Wells) (Con)]

I join the Secretary of State and the shadow Secretary of State in extending sympathy to those who have died of the virus and admiration for NHS staff members and others who are coping with it. May I press my right hon. Friend on testing? First, if we are relying on scientific evidence, it is important that we are transparent about it. When will he publish the scientific evidence that he mentioned in his statement? Secondly, there has been a change in policy on testing. Up to the end of last week, people could be tested via drive-in or home visits; that is no longer the case. Is that because there is not the necessary quantity of test kits available? If so, will that type of test be restored when they are available, and when does he expect that to be?

[Matt Hancock]

At the start, when the number of cases was very small, we had enough tests to test everyone who had suspected symptoms. The number of cases has risen exponentially and the number of tests has been increased, but we need to make sure that the tests we have available are there for saving lives. We hope that the introduction of a home test or equipment for bedside testing, which my right hon. Friend and I have discussed previously, will enable us to increase the number of tests radically, and get ahead of the epidemiological curve as soon as possible. We are in live negotiations about bringing that in.

Coronavirus

Debate between Matt Hancock and Greg Clark

Wednesday 11th March 2020 Commons Chamber

[Matt Hancock]

As the hon. Lady knows, guidance is coming out this week. She is right about the importance of protective equipment, and of course, we are taking that into account. The Chancellor set out that more money will be available in social care if it is needed—and I expect that it will be—and announced a total of up to £5 billion for the NHS and social care, while saying that his door is open should more be needed. These are all very important considerations, and the guidance will be out shortly.

[Greg Clark (Tunbridge Wells) (Con)]

I welcome my right hon. Friend’s determination to base his actions on what he calls the “bedrock” of the science. He will be aware that the World Health Organisation-China joint mission report drew particular attention to the importance of the rapid expansion of detection and diagnosis as a way to prevent illness and death. The daily number of tests in this country has been relatively stable over the last few days. In fact, it fell between 7 March and 10 March, while the number of cases increased. Can he assure the House that the right number of people are being tested? When will the expansion of testing that he announced yesterday translate from capacity into the actual number of people being tested?

[Matt Hancock]

That is a very important consideration. As I said, the number of labs doing testing has already gone from one to 12, and we are working with more than two dozen companies on further testing capability. We are rolling out a big expansion of testing. The critical thing is to ensure that it is not just about the testing. Getting the whole pathway right—from somebody feeling sick to calling 111, being tested and then getting the test result back—as the number of tests goes up is the critical thing we have to do.

Coronavirus

Debate between Matt Hancock and Greg Clark

Monday 9th March 2020 Commons Chamber

[Matt Hancock]

As I said, we see no purpose for suspending Parliament, and parliamentary accountability is very important, as is the legislative power of Parliament.

[Greg Clark (Tunbridge Wells) (Con)]

On the day Carillion collapsed, all the UK banks, through UK Finance, agreed forbearance on the loans and overdrafts of small businesses affected. Has Cobra obtained the same assurance from the banks in respect of businesses affected by the coronavirus?

Coronavirus

Debate between Matt Hancock and Greg Clark

Tuesday 3rd March 2020 Commons Chamber

[Matt Hancock]

We have a huge amount of work under way, including looking at what we can do to ensure that people can get support in care homes. It is not just about the staff, of course; elderly people in care homes are, according to the data, among those most vulnerable to the disease. The care home element of our plan is incredibly important and we will be providing more details in the coming days.

[Greg Clark (Tunbridge Wells) (Con)]

It is very important that both the resolution and the management of the crisis are based on the best possible science, and I join the Secretary of State’s tribute to the UK scientists, who are among the most experienced and best qualified in the world. Have UK scientists been part of the World Health Organisation teams deployed to Iran and China? Does the Government’s chief scientific adviser attend the Cobra meetings? Can the Secretary of State update me on the question, about which I wrote to him on Thursday, of when we can expect a bedside test to be deployed in this country and made available around the world?

[Matt Hancock]

We are, of course, involved in the World Health Organisation missions and in some direct bilateral missions. I have repeatedly signed off on support for more UK experts to go out around the world. The chief scientific adviser is, of course, at all the Cobra meetings on this, whether they are chaired by me or by the Prime Minister.

My right hon. Friend’s point on the bedside test is incredibly important. We are currently engaged with just over a dozen companies to try to come up with a bedside test, instead of having to take a swab from the back of your throat, Mr Speaker—should you have the misfortune to fall ill—having it sent away and brought back. Working with UK companies to get a bedside test that can be done on the premises is an incredibly important part of the diagnostic mission surrounding this disease.

Coronavirus

Debate between Matt Hancock and Greg Clark

Wednesday 26th February 2020 Commons Chamber

[Greg Clark (Tunbridge Wells) (Con)]

Has the roll-out of diagnostic testing facilities to 11 laboratories in the UK been completed? Does my right hon. Friend have plans to extend that coverage if there were to be a wider outbreak?

[Matt Hancock]

There has been a roll-out to a wider number of laboratories, and we are working through plans for wider commercial diagnostic testing. We are working with around a dozen private companies, and using private diagnostic testing companies, not least because globally there is a search for a “by the side of the bed” testing capability. At the moment, all testing is done in labs, which means that someone has to take a swab to the lab and get the result. We want testing capabilities that involve a bit of kit by the bedside of the patient, so that tests can be run onsite. There is a global search for that capability, but it does not yet exist. We are putting funding and support into making that happen, and I hope we will soon get to that solution.

Oral Answers to Questions

Debate between Matt Hancock and Greg Clark

Monday 31st October 2011 Commons Chamber

[Greg Clark]

My hon. Friend is absolutely right—and when I was talking to the Secretary of State earlier, he extolled the virtues of the pies available at the Norfolk food festival. We must take into account the long-term value of food security as well as the short and medium-term economic benefits of food production.

[Matthew Hancock (West Suffolk) (Con)]

9. What steps he is taking to help local authorities reduce the cost of their property.